Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Depression and other common mental disorders: Global health estimates..(Available at:)http://apps.who.int/iris/handle/10665/254610Date: 2017Date accessed: November 21, 2018
- Reduced Kv3.1 activity in dentate gyrus parvalbumin cells induces vulnerability to depression.Biol Psychiatry. 2020; 88: 405-414
- A brief history of antidepressant drug development: From tricyclics to beyond ketamine.Acta Neuropsychiatr. 2018; 30: 307-322
- A historical review of antidepressant effects of ketamine and its enantiomers.Pharmacol Biochem Behav. 2020; 190: 172870
- From neurobiology to novel medications: A principled approach to translation.Am J Psychiatry. 2019; 176: 425-427
- Alterations in 5-HT1B receptor function by p11 in depression-like states.Science. 2006; 311: 77-80
- Modulation of ion channels and receptors by p11 (S100A10).Trends Pharmacol Sci. 2020; 41: 487-497
- The dentate gyrus in depression [published online ahead of print Dec 7].Eur J Neurosci. 2019;
- Biophysical characterization of KV3.1 potassium channel activating compounds.Eur J Pharmacol. 2015; 758: 164-170
- Hippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus.Nature. 2018; 559: 98-102